Literature DB >> 8001128

Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy.

J Sloan-Lancaster1, A S Shaw, J B Rothbard, P M Allen.   

Abstract

Studies of T cell responses to altered peptide ligands (APLs) have provided functional evidence that a T cell receptor (TCR) can interpret subtle changes in its ligand, resulting in different phenotypic outcomes. One dramatic effect of APL stimulation with live antigen-presenting cells (APCs) is the induction of energy as opposed to proliferation. We investigated the intracellular signaling events involved in generating this unresponsiveness by comparing protein-tyrosine phosphorylation patterns after stimulation with anergy-inducing APL or the immunogenic peptide. In resting T cell clones, presentation with APL/live APC stimulated a unique pattern of TCR phospho-zeta species and a subsequent lack of association with zap70. This demonstrates that the TCR-CD3 complex can engage selective intracellular biochemical signaling pathways as a direct consequence of the nature of the ligand recognized and the initial phosphotyrosine pattern of the TCR-CD3 proteins, leading to different phenotypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001128     DOI: 10.1016/0092-8674(94)90080-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  150 in total

1.  Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.

Authors:  R T Meijer; S L Yong; I J ten Berge; R A van Lier; P T Schellekens
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Combinatorial effect of T-cell receptor ligation and CD45 isoform expression on the signaling contribution of the small GTPases Ras and Rap1.

Authors:  J Czyzyk; D Leitenberg; T Taylor; K Bottomly
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 3.  The contributions of T-cell anergy to peripheral T-cell tolerance.

Authors:  R Lechler; J G Chai; F Marelli-Berg; G Lombardi
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 4.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

5.  Anergy in CD4 memory T lymphocytes. II. Abrogation of TCR-induced formation of membrane signaling complexes.

Authors:  William T Lee; Aparna Prasad; Andrew R O Watson
Journal:  Cell Immunol       Date:  2012-05-19       Impact factor: 4.868

Review 6.  Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Paul M Allen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 7.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

8.  Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide.

Authors:  C N Levelt; E Mizoguchi; X Huang; R Zacks; A K Bhan; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes.

Authors:  A Faber-Elmann; M Paas-Rozner; M Sela; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  In vivo antagonism of a T cell response by an endogenously expressed ligand.

Authors:  D Basu; C B Williams; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.